IL13 and inflammatory bowel disease: ToxoROP16I/III promotes the polarization of M2 cells, and enhances the synthesis of Arg-1, IL-10, transforming growth factor-β1, and IL-13, which may ameliorate the pathogenesis of inflammatory bowel disease in an in vitro experimental model (45).